Skip to content

Matthews International MATW Effect of dilutive RSUs and PSUs (in shares)

Effect of dilutive RSUs and PSUs (in shares) at other companies

Popular logo
PopularBPOP
39.2K+42.2%
Avanos Medical logo
Avanos MedicalAVNS
1M+42.9%
McCormick & Company, Incorporated logo
McCormick & Company, IncorporatedMKC
0-100%
Morgan Stanley logo
Morgan StanleyMS
15M-6.3%
First BanCorp logo
First BanCorpFBP
839K+2.9%
Lincoln National logo
Lincoln NationalLNC
-$5M

Other financials

Income statement

See full
Revenue$258.6M-39.5%
Gross profit$102.0M-29.2%
Operating income-$3.2M-153%
Net income-$21.8M-145%
EPS (diluted)-$0.69-138%

Balance sheet

See full
Cash & equivalents$36.1M-10.3%
Total debt$662.1M-26.6%
Total equity$512.2M+25.5%
Total assets$1.5B-16.2%

Cash flow

See full
Operating cash flow-$15.4M
CapEx$4.0M-53.7%
Free cash flow-$19.5M-708%

Valuation

See full
Market cap$821.56M+26.0%
Enterprise value$1.45B-4.4%
P/E84.6×
P/S0.7×+0.3×

Profitability

See full
Gross margin36.3%+5.8pp
Operating margin2.3%-1.2pp
Net margin0.8%+0.4pp
FCF margin-8.3%-8.8pp

Returns & leverage

See full
Return on equity2.1%+1.1pp
Debt / equity1.3×-0.9×
Current ratio1.6×0.0×

Where this comes from

Reported directly by Matthews International in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment.

The official record: Matthews International’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Matthews International's effect of dilutive rsus and psus (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Matthews International's effect of dilutive rsus and psus (in shares)?
Matthews International (MATW) reported effect of dilutive rsus and psus (in shares) of $0 in Q1 2026.
What is the long-term trend for Matthews International's effect of dilutive rsus and psus (in shares)?
Over 3 years (2022 to 2025), Matthews International's effect of dilutive rsus and psus (in shares) has grown at a -51.6% compound annual growth rate (CAGR), from $308K to $35K.